Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Top Cited Papers
- 2 April 2001
- journal article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 20 (7), 1774-1784
- https://doi.org/10.1093/emboj/20.7.1774
Abstract
Alternative splicing of human cystic fibrosis transmembrane conductance regulator (CFTR) exon 9 is regulated by a combination of cis‐acting elements distributed through the exon and both flanking introns (IVS8 and IVS9). Several studies have identified in the IVS8 intron 3′ splice site a regulatory element that is composed of a polymorphic (TG)m(T)n repeated sequence. At present, no cellular factors have been identified that recognize this element. We have identified TDP‐43, a nuclear protein not previously described to bind RNA, as the factor binding specifically to the (TG)m sequence. Transient TDP‐43 overexpression in Hep3B cells results in an increase in exon 9 skipping. This effect is more pronounced with concomitant overexpression of SR proteins. Antisense inhibition of endogenous TDP‐43 expression results in increased inclusion of exon 9, providing a new therapeutic target to correct aberrant splicing of exon 9 in CF patients. The clinical and biological relevance of this finding in vivo is demonstrated by our characterization of a CF patient carrying a TG10T9(ΔF508)/TG13T3(wt) genotype leading to a disease‐causing high proportion of exon 9 skipping.Keywords
This publication has 35 references indexed in Scilit:
- Splicing Factors Induce Cystic Fibrosis Transmembrane Regulator Exon 9 Skipping through a Nonevolutionary Conserved Intronic ElementJournal of Biological Chemistry, 2000
- Allergic Bronchopulmonary AspergillosisAnnual Review of Medicine, 1999
- Tetranucleotide GGGA Motif in Primary RNA TranscriptsPublished by Elsevier BV ,1998
- The impact of L1 retrotransposons on the human genomeNature Genetics, 1998
- Amplification of CFTR Exon 9 Sequences to Multiple Locations in the Human GenomeGenomics, 1997
- Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas DeferensNew England Journal of Medicine, 1995
- Distinct Binding Specificities and Functions of Higher Eukaryotic Polypyrimidine Tract-Binding ProteinsScience, 1995
- Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasisHuman Molecular Genetics, 1995
- Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channelsNature Genetics, 1993
- Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductanceHuman Molecular Genetics, 1993